conversation
To sponsor this category, click here | subscribe to this category RSS

Home » Archives for conversation

No Image

Using Social Media in a Crisis : Distribute a Product Safety Widget Is One Idea

Tuesday, July 27th, 2010

The “Social Media During a Crisis” roundtable discussion lead by Deborah Sittig ( @GreenRoomMedia ), Partner at Green Room Public Relations, was one of the most interesting events for me at ExL Pharma’s 6th Annual Public Relations & Communications Summit .

Read the full story

On Being Voted Off the Social Media Island

Friday, July 23rd, 2010

Here’s a bit of irony.

Read the full story

Kopelow On CME: ‘We Trust There Won’t Be Fraud’

Tuesday, June 29th, 2010

Continuing medical education is always controversial, given concerns over undue industry influence on medical practice. But CME roared back into public view earlier this month when several leading policy makers and physicians – including the National Institutes of Health director – publicly objected to a rule promulgated by the Accreditation Council for Continuing Medical Education, which would prevent doctors from receiving needed credit for attending medical meetings where industry people talk about their drugs

Read the full story

Deception and deceipt on social media

Thursday, May 27th, 2010

It’s easy for a pharma employee to set up a bogus social media account and violate FDA/DDMAC rules and guidelines. There are literally thousands of social media posts every minute of every day and frankly there is no way to really stop pharma and medical device employees from going on Twitter and making off-label or false claims

Read the full story

What an exciting time to be in DTC marketing

Saturday, May 22nd, 2010

There are a lot of great quotes around change but the fact of the matter is that most people don’t embrace change because they are afraid of what change can mean. DTC marketing has been in a funk for a long time but consumers and patients are going to force DTC marketers to think out of the box and if drug marketing to consumers is to continue to be measured than new ways are going to have to be found to interact with patients

Posted in: DTC | 0 Comments »
Read the full story

Live from BIO 2010: A human face for the drug industry

Monday, May 3rd, 2010

Yesterday I left Philadelphia for FierceBiotech’s annual trip to

Read the full story

Pharma Should Leave Unmoderated SM Discussions to 3rd Parties

Friday, March 5th, 2010

In comments addressed to the FDA, many drug companies and ad hoc industry groups are suggesting ways drug companies can legally “engage” with patients, physicians, and consumers in online social media discussions (see, for example, ” A Pharma ‘Social Media Working Group’ Submits Comments to FDA “).

Read the full story

Disclosure: Does it blur the facts ?

Wednesday, February 24th, 2010

I’m used to Ed Silverman’s constant attack on pharma via his Pharmalot BLOG. It seems he goes out of his way to point out everything that is wrong with pharma while never having worked a day in the industry. However journalists seem to get a “pass” when it comes to voicing their opinions

Posted in: DTC | 0 Comments »
Read the full story

Lessons from Toyota disaster for the drug industry

Thursday, February 4th, 2010

According to a story from Newsweek titled Toyota’s Digital Disaster; How much more difficult does the Internet make crisis management? It’s a crucial front, and you have got to be there.

Read the full story

Should pharma develop Facebook pages ?

Tuesday, January 26th, 2010

What happened to Twitter? The answer to that is the reason for its decline: nothing

Read the full story